首页 > 最新文献

中华放射肿瘤学杂志最新文献

英文 中文
Research progresson neoadjuvant chemoradiotherapy for locally advanced rectal cancer 局部晚期直肠癌新辅助放化疗的研究进展
Pub Date : 2020-03-15 DOI: 10.3760/CMA.J.ISSN.1004-4221.2020.03.015
Yiru Wang, Yong Zhang, Tong Wu, Meizhu Shen
Preoperative neoadjuvant chemoradiotherapy (NCR) combined with total mesorectal excision (TME) is the standard treatment mode for locally advanced rectal cancer. Compared with postoperative NCR, preoperative NCR increases the tumor down-staging, sphincter-preserving rate and local control rate. Patients who attain pathological complete response (pCR) after preoperative NCR have better prognosis compared with their counterparts. This article reviews the research progress on preoperative NCR in recent years. Key words: Rectal neoplasm/radiochemotherapy; Radiochemotherapy, neoadjuvant; Research progress
术前新辅助放化疗(NCR)联合全肠系膜切除(TME)是局部晚期直肠癌的标准治疗模式。与术后NCR相比,术前NCR可提高肿瘤降期、括约肌保留率和局部控制率。术前NCR后达到病理完全缓解(pCR)的患者预后较好。本文综述了近年来术前NCR的研究进展。关键词:直肠肿瘤/放化疗;Radiochemotherapy新辅助;研究进展
{"title":"Research progresson neoadjuvant chemoradiotherapy for locally advanced rectal cancer","authors":"Yiru Wang, Yong Zhang, Tong Wu, Meizhu Shen","doi":"10.3760/CMA.J.ISSN.1004-4221.2020.03.015","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1004-4221.2020.03.015","url":null,"abstract":"Preoperative neoadjuvant chemoradiotherapy (NCR) combined with total mesorectal excision (TME) is the standard treatment mode for locally advanced rectal cancer. Compared with postoperative NCR, preoperative NCR increases the tumor down-staging, sphincter-preserving rate and local control rate. Patients who attain pathological complete response (pCR) after preoperative NCR have better prognosis compared with their counterparts. This article reviews the research progress on preoperative NCR in recent years. \u0000 \u0000Key words: \u0000Rectal neoplasm/radiochemotherapy; Radiochemotherapy, neoadjuvant; Research progress","PeriodicalId":10288,"journal":{"name":"Chinese Journal of Radiation Oncology","volume":"29 1","pages":"225-228"},"PeriodicalIF":0.0,"publicationDate":"2020-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43557468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A study of an independent dose verification software for brachytherapy 近距离放射治疗独立剂量验证软件的研究
Pub Date : 2020-02-15 DOI: 10.3760/CMA.J.ISSN.1004-4221.2020.02.012
Xianliang Wang, Pei Wang, Churong Li, Jie Li, Shengwei Kang, Min Liu, Ta-Wei Ting, Zhangwen Wu, Q. Hou
Objective To report an implementation method and results of an independent brachytherapy dose verification software (DVS). Methods The DVS was developed based on Visual C+ + and the modular structure design was adopted. The DICOM RT files exported from the treatment planning system (TPS) were automatically loaded into the DVS. The TG-43 formalism was employed for dose calculation. Six cervical cancer patients who underwent brachytherapy were retrospectively selected to test the DVS. Different applicators were utilized for each patient. Dosimetric parameters and γ analysis (0.1cm, 5%) were used to evaluate the dose difference between the DVS and the TPS. Results Compared with the TPS dose, the γ pass rates of the doses calculated by the DVS were higher than 98%. For CTV, the dosimetric differences were less than 0.29% and 0.53% for D100% and D90%. For bladder, rectum and sigmoid, the agreement of D0.1cm3, D1cm3 and D2cm3 within a 0.5% level. Conclusion With minimal human-computer interactions, the DVS can verify the accuracy of dose calculated by TPS for brachytherapy. Key words: Brachytherapy; Dose verification; Treatment planning system; Quality assurance
目的报告一种独立的近距离放射治疗剂量验证软件(DVS)的实现方法和结果。方法基于Visual C++开发DVS,采用模块化结构设计。从治疗计划系统(TPS)导出的DICOM RT文件被自动加载到DVS中。TG-43形式用于剂量计算。回顾性选择6例接受近距离放射治疗的癌症患者进行DVS测试。每个患者使用不同的治疗器。剂量测定参数和γ分析(0.1cm,5%)用于评估DVS和TPS之间的剂量差异。结果与TPS剂量相比,DVS计算的剂量γ通过率高于98%。对于CTV,D100%和D90%的剂量测定差异分别小于0.29%和0.53%。对于膀胱、直肠和乙状结肠,D0.1cm3、D1cm3和D2cm3的一致性在0.5%的水平内。结论DVS可以在最小的人机交互下验证TPS计算的近距离放射治疗剂量的准确性。关键词:近距离治疗;剂量验证;治疗计划体系;质量保证
{"title":"A study of an independent dose verification software for brachytherapy","authors":"Xianliang Wang, Pei Wang, Churong Li, Jie Li, Shengwei Kang, Min Liu, Ta-Wei Ting, Zhangwen Wu, Q. Hou","doi":"10.3760/CMA.J.ISSN.1004-4221.2020.02.012","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1004-4221.2020.02.012","url":null,"abstract":"Objective \u0000To report an implementation method and results of an independent brachytherapy dose verification software (DVS). \u0000 \u0000 \u0000Methods \u0000The DVS was developed based on Visual C+ + and the modular structure design was adopted. The DICOM RT files exported from the treatment planning system (TPS) were automatically loaded into the DVS. The TG-43 formalism was employed for dose calculation. Six cervical cancer patients who underwent brachytherapy were retrospectively selected to test the DVS. Different applicators were utilized for each patient. Dosimetric parameters and γ analysis (0.1cm, 5%) were used to evaluate the dose difference between the DVS and the TPS. \u0000 \u0000 \u0000Results \u0000Compared with the TPS dose, the γ pass rates of the doses calculated by the DVS were higher than 98%. For CTV, the dosimetric differences were less than 0.29% and 0.53% for D100% and D90%. For bladder, rectum and sigmoid, the agreement of D0.1cm3, D1cm3 and D2cm3 within a 0.5% level. \u0000 \u0000 \u0000Conclusion \u0000With minimal human-computer interactions, the DVS can verify the accuracy of dose calculated by TPS for brachytherapy. \u0000 \u0000 \u0000Key words: \u0000Brachytherapy; Dose verification; Treatment planning system; Quality assurance","PeriodicalId":10288,"journal":{"name":"Chinese Journal of Radiation Oncology","volume":"29 1","pages":"131-135"},"PeriodicalIF":0.0,"publicationDate":"2020-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47466553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comparative analysis of SRT and SRS in the treatment of brain metastases from lung adenocarcinoma SRT和SRS治疗肺腺癌脑转移的对比分析
Pub Date : 2020-02-15 DOI: 10.3760/CMA.J.ISSN.1004-4221.2020.02.002
Yong Li, Fenghua Liu, Kangning Liang, Xianjun Shao, Li Zhang, Xiaohua Liang, Mianshun Pan
Objective To compare the clinical efficacy of stereotactic radiotherapy (SRT) and stereotactic radiosurgery (SRS) in the treatment of brain metastases from January 2006 to December 2016, lung adenocarcinoma and analyze the related factors. Methods In this multi-center retrospective analysis, clinical data of 208 patients with brain metastases from lung adenocarcinoma were retrospectively analyzed and assigned into the SRT (n=86) and SRS groups (n=122). The clinical characteristics of patients in two groups were analyzed. The local tumor control rate, median survival time and radiation brain injury were statistically compared between two groups. Results At the end of follow-up, the objective response rates (ORR) were 70.9% and 71.3% in the SRT and SRS groups (P=0.772). The local tumor control rates at 12 months were 89% and 86% in the SRT and SRS groups (P=0.383). The median overall survival time of all patients was 14.3 months, 15.6 months in the SRT group and 13.7 months in the SRS group (P=0.349). Multivariate analysis showed that large target volume (P<0.001), low GPA score (P=0.012) and no insensitive gene mutation (P<0.001) were the main factors of poor prognosis. The incidence of late radiation brain injury was 5.8% and 14.8% in two groups (P=0.043). Conclusions SRT and SRS yield similar clinical efficacy in the treatment of brain metastases from lung adenocarcinoma. SRT may have a lower incidence of late radiation brain injury than SRS. Key words: Brain metastasis/lung neoplasms; Stereotactic radiotherapy; Stereotactic radiosurgery
目的比较2006年1月至2016年12月立体定向放疗(SRT)与立体定向放射手术(SRS)治疗脑转移性肺腺癌的临床疗效,并分析相关因素。方法对208例肺腺癌脑转移患者的临床资料进行回顾性分析,分为SRT组(n=86)和SRS组(n=122)。分析两组患者的临床特点。对两组局部肿瘤控制率、中位生存时间及放射性脑损伤进行统计学比较。结果随访结束时,SRT组和SRS组的客观有效率(ORR)分别为70.9%和71.3% (P=0.772)。SRT组和SRS组12个月局部肿瘤控制率分别为89%和86% (P=0.383)。所有患者的中位总生存时间为14.3个月,SRT组为15.6个月,SRS组为13.7个月(P=0.349)。多因素分析显示,靶体积大(P<0.001)、GPA评分低(P=0.012)、无不敏感基因突变(P<0.001)是导致预后不良的主要因素。两组晚期放射性脑损伤发生率分别为5.8%和14.8% (P=0.043)。结论SRT与SRS治疗肺腺癌脑转移的临床疗效相近。SRT可能比SRS有更低的晚期放射性脑损伤发生率。关键词:脑转移/肺肿瘤;立体定向放射治疗;立体定向放射治疗
{"title":"A comparative analysis of SRT and SRS in the treatment of brain metastases from lung adenocarcinoma","authors":"Yong Li, Fenghua Liu, Kangning Liang, Xianjun Shao, Li Zhang, Xiaohua Liang, Mianshun Pan","doi":"10.3760/CMA.J.ISSN.1004-4221.2020.02.002","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1004-4221.2020.02.002","url":null,"abstract":"Objective \u0000To compare the clinical efficacy of stereotactic radiotherapy (SRT) and stereotactic radiosurgery (SRS) in the treatment of brain metastases from January 2006 to December 2016, lung adenocarcinoma and analyze the related factors. \u0000 \u0000 \u0000Methods \u0000In this multi-center retrospective analysis, clinical data of 208 patients with brain metastases from lung adenocarcinoma were retrospectively analyzed and assigned into the SRT (n=86) and SRS groups (n=122). The clinical characteristics of patients in two groups were analyzed. The local tumor control rate, median survival time and radiation brain injury were statistically compared between two groups. \u0000 \u0000 \u0000Results \u0000At the end of follow-up, the objective response rates (ORR) were 70.9% and 71.3% in the SRT and SRS groups (P=0.772). The local tumor control rates at 12 months were 89% and 86% in the SRT and SRS groups (P=0.383). The median overall survival time of all patients was 14.3 months, 15.6 months in the SRT group and 13.7 months in the SRS group (P=0.349). Multivariate analysis showed that large target volume (P<0.001), low GPA score (P=0.012) and no insensitive gene mutation (P<0.001) were the main factors of poor prognosis. The incidence of late radiation brain injury was 5.8% and 14.8% in two groups (P=0.043). \u0000 \u0000 \u0000Conclusions \u0000SRT and SRS yield similar clinical efficacy in the treatment of brain metastases from lung adenocarcinoma. SRT may have a lower incidence of late radiation brain injury than SRS. \u0000 \u0000 \u0000Key words: \u0000Brain metastasis/lung neoplasms; Stereotactic radiotherapy; Stereotactic radiosurgery","PeriodicalId":10288,"journal":{"name":"Chinese Journal of Radiation Oncology","volume":"29 1","pages":"88-92"},"PeriodicalIF":0.0,"publicationDate":"2020-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47299498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term efficacy and adverse reactions of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma in non-endemic northwest China 西北非地方性鼻咽癌调强放疗的远期疗效及不良反应分析
Pub Date : 2020-02-15 DOI: 10.3760/CMA.J.ISSN.1004-4221.2020.02.001
Man Xu, M. Shi, J. Zang, Jan-hong Wang, Lina Zhao, S. Luo, F. Xiao
Objective To retrospectively analyze the characteristics of nasopharyngeal carcinoma, long-term efficacy, adverse reactions of intensity-modulated radiotherapy (IMRT) in non-endemic northwest China and summarize the experience of IMRT in the treatment of nasopharyngeal carcinoma in the past decade. Methods Clinical data of 658 patients newly diagnosed with nasopharyngeal carcinoma without distant metastasis admitted to First affiliated hospital from January 2006 to December 2016 were retrospectively analyzed. All patients were treated with IMRT. The survival analysis was performed by Kaplan-Meier method. The multivariate analysis was conducted with Cox’s regression model. Results In non-endemic northwest China, a large proportion of patients were newly diagnosed with locally advanced nasopharyngeal carcinoma, and a majority of them were pathologically characterized as differentiated subtypes. The 5-year overall survival (OS), disease-free survival (DFS), local recurrence-free survival (LRFS), regional recurrence-free survival (RRFS) and distant metastasis-free survival (DMFS) rates were 75.7%, 70.1%, 91.2%, 97.0% and 81.0%, respectively. Multivariate analysis showed that age, pathological type, nasopharyngeal tumor volume>23 cm3 and neck lymph node metastasis complicated with necrosis were the factors of poor prognosis of DFS (all P<0.05). Age, pathological type, neck lymph node metastasis complicated with necrosis were the factors of poor prognosis of OS (all P<0.05). N stage and neck lymph node metastasis complicated with necrosis were the factors of poor prognosis of DMFS (both P<0.05). Conclusions Similar clinical efficacy has been achieved in terms of IMRT for nasopharyngeal carcinoma in non-endemic northwest China compared with that in endemic area. Induction chemotherapy combined with concurrent radiochemotherapy can provide clinical benefits for patients with locally advanced nasopharyngeal carcinoma in non-endemic area. Key words: Nasopharyngeal neoplasm/intensity-modulated radiotherapy; Non-endemic area; Prognosis
目的回顾性分析西北地区非地方性鼻咽癌调强放疗(IMRT)的特点、远期疗效及不良反应,总结近十年来调强放疗治疗鼻咽癌的经验。方法回顾性分析2006年1月至2016年12月第一附属医院收治的658例初诊鼻咽癌无远处转移患者的临床资料。所有患者均接受IMRT治疗。生存率分析采用Kaplan-Meier法。采用Cox回归模型进行多因素分析。结果在西北地区,局部进展期鼻咽癌的新诊断患者占很大比例,多数患者病理表现为分化亚型。5年总生存率(OS)、无病生存率(DFS)、局部无复发生存率(LRFS)、区域无复发生存率(RRFS)和远处无转移生存率(DMFS)分别为75.7%、70.1%、91.2%、97.0%和81.0%。多因素分析显示,年龄、病理类型、鼻咽肿瘤体积bbb23 cm3、颈部淋巴结转移合并坏死是影响DFS预后的因素(均P<0.05)。年龄、病理类型、颈部淋巴结转移合并坏死是影响OS预后的因素(均P<0.05)。N分期及颈部淋巴结转移合并坏死是DMFS预后不良的因素(P<0.05)。结论西北地区鼻咽癌非流行区与流行区相比,IMRT治疗鼻咽癌的临床疗效相近。诱导化疗联合放化疗可为非流行区局部晚期鼻咽癌患者提供临床获益。关键词:鼻咽肿瘤/调强放疗;非区域;预后
{"title":"Long-term efficacy and adverse reactions of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma in non-endemic northwest China","authors":"Man Xu, M. Shi, J. Zang, Jan-hong Wang, Lina Zhao, S. Luo, F. Xiao","doi":"10.3760/CMA.J.ISSN.1004-4221.2020.02.001","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1004-4221.2020.02.001","url":null,"abstract":"Objective \u0000To retrospectively analyze the characteristics of nasopharyngeal carcinoma, long-term efficacy, adverse reactions of intensity-modulated radiotherapy (IMRT) in non-endemic northwest China and summarize the experience of IMRT in the treatment of nasopharyngeal carcinoma in the past decade. \u0000 \u0000 \u0000Methods \u0000Clinical data of 658 patients newly diagnosed with nasopharyngeal carcinoma without distant metastasis admitted to First affiliated hospital from January 2006 to December 2016 were retrospectively analyzed. All patients were treated with IMRT. The survival analysis was performed by Kaplan-Meier method. The multivariate analysis was conducted with Cox’s regression model. \u0000 \u0000 \u0000Results \u0000In non-endemic northwest China, a large proportion of patients were newly diagnosed with locally advanced nasopharyngeal carcinoma, and a majority of them were pathologically characterized as differentiated subtypes. The 5-year overall survival (OS), disease-free survival (DFS), local recurrence-free survival (LRFS), regional recurrence-free survival (RRFS) and distant metastasis-free survival (DMFS) rates were 75.7%, 70.1%, 91.2%, 97.0% and 81.0%, respectively. Multivariate analysis showed that age, pathological type, nasopharyngeal tumor volume>23 cm3 and neck lymph node metastasis complicated with necrosis were the factors of poor prognosis of DFS (all P<0.05). Age, pathological type, neck lymph node metastasis complicated with necrosis were the factors of poor prognosis of OS (all P<0.05). N stage and neck lymph node metastasis complicated with necrosis were the factors of poor prognosis of DMFS (both P<0.05). \u0000 \u0000 \u0000Conclusions \u0000Similar clinical efficacy has been achieved in terms of IMRT for nasopharyngeal carcinoma in non-endemic northwest China compared with that in endemic area. Induction chemotherapy combined with concurrent radiochemotherapy can provide clinical benefits for patients with locally advanced nasopharyngeal carcinoma in non-endemic area. \u0000 \u0000 \u0000Key words: \u0000Nasopharyngeal neoplasm/intensity-modulated radiotherapy; Non-endemic area; Prognosis","PeriodicalId":10288,"journal":{"name":"Chinese Journal of Radiation Oncology","volume":"29 1","pages":"81-87"},"PeriodicalIF":0.0,"publicationDate":"2020-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46923628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect and mechanism of down-regulating REV7 expression on the radiosensitivity of human colon cancer cell HCT116 下调REV7表达对人结肠癌细胞HCT116放射敏感性的影响及机制
Pub Date : 2020-02-15 DOI: 10.3760/CMA.J.ISSN.1004-4221.2020.02.008
C. Yuan, Lu Ma, Feifei Kong
Objective To evaluate the effect and mechanism of down-regulating the expression of REV7 on the radiosensitivity of human colon cancer cell HCT116. Methods HCT116 cells were cultured and the expression of REV7 was down-regulated by RNA interference technique. HCT116 cells were divided into the blank group, negative control transfected with negative RNA oligo group and REV7 expression down-regulation transfected with REV7 RNA oligo group, respectively. The cell proliferation was determined by colony formation assay. The expression levels of the proteins of relevant genes were detected by Western blot. The level of cell apoptosis and non-homologous end joining was evaluated. Results The colony formation rate was significantly reduced in THE REV7 siRNA group after 6Gy irradiation (P 60% in the REV7 siRNA group. The expression levels of γH2AX and Caspase9 were significantly up-regulated, whereas those of KU80 and XRCC4 were remarkably down-regulated in the REV7 siRNA group (all P<0.05). Conclusions The radiosensitivity of human colon cancer cell HCT116 can be increased by down-regulating the expression of REV7. The underlying mechanism may be related to the lower incidence rate of non-homologous end joining. Key words: REV7 gene; HCT116 cell line; Radiosensitivity; Non-homologous end joining
目的探讨下调REV7表达对人结肠癌细胞HCT116放射敏感性的影响及其机制。方法培养HCT116细胞,采用RNA干扰技术下调REV7的表达。将HCT116细胞分别分为空白组、阴性对照转染负RNA寡核苷酸组和REV7表达下调转染REV7寡核苷酸组。用菌落形成法测定细胞增殖情况。Western blot检测相关基因蛋白表达水平。观察细胞凋亡和非同源末端连接的水平。结果经6Gy辐照后,The REV7 siRNA组细胞集落形成率明显降低(P < 60%)。在REV7 siRNA组中,γ - h2ax和Caspase9的表达水平显著上调,KU80和XRCC4的表达水平显著下调(均P<0.05)。结论下调REV7的表达可提高人结肠癌细胞HCT116的放射敏感性。其潜在机制可能与非同源末端连接发生率较低有关。关键词:REV7基因;HCT116细胞系;辐射敏感度;非同源端连接
{"title":"Effect and mechanism of down-regulating REV7 expression on the radiosensitivity of human colon cancer cell HCT116","authors":"C. Yuan, Lu Ma, Feifei Kong","doi":"10.3760/CMA.J.ISSN.1004-4221.2020.02.008","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1004-4221.2020.02.008","url":null,"abstract":"Objective \u0000To evaluate the effect and mechanism of down-regulating the expression of REV7 on the radiosensitivity of human colon cancer cell HCT116. \u0000 \u0000 \u0000Methods \u0000HCT116 cells were cultured and the expression of REV7 was down-regulated by RNA interference technique. HCT116 cells were divided into the blank group, negative control transfected with negative RNA oligo group and REV7 expression down-regulation transfected with REV7 RNA oligo group, respectively. The cell proliferation was determined by colony formation assay. The expression levels of the proteins of relevant genes were detected by Western blot. The level of cell apoptosis and non-homologous end joining was evaluated. \u0000 \u0000 \u0000Results \u0000The colony formation rate was significantly reduced in THE REV7 siRNA group after 6Gy irradiation (P 60% in the REV7 siRNA group. The expression levels of γH2AX and Caspase9 were significantly up-regulated, whereas those of KU80 and XRCC4 were remarkably down-regulated in the REV7 siRNA group (all P<0.05). \u0000 \u0000 \u0000Conclusions \u0000The radiosensitivity of human colon cancer cell HCT116 can be increased by down-regulating the expression of REV7. The underlying mechanism may be related to the lower incidence rate of non-homologous end joining. \u0000 \u0000 \u0000Key words: \u0000REV7 gene; HCT116 cell line; Radiosensitivity; Non-homologous end joining","PeriodicalId":10288,"journal":{"name":"Chinese Journal of Radiation Oncology","volume":"29 1","pages":"115-117"},"PeriodicalIF":0.0,"publicationDate":"2020-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47491180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A verification study of Offset values of different applicators in afterloading brachytherapy 后负荷近距离治疗中不同施药器偏移值的验证研究
Pub Date : 2020-02-15 DOI: 10.3760/CMA.J.ISSN.1004-4221.2020.02.011
Min Liu, Xianliang Wang, K. Yuan, B. Wan, Feng Yang, Shengwei Kang, Jie Li
Objective To investigate the Offset values of different applicators in afterloading brachytherapy. Methods Six types of applicators were selected in this study which included stainless steel interstitial needle (Part#083.062), proguide round needle (Part#189.608), proguide sharp needle (Part#189.601), vaginal multi-channel applicator (Part#110.800), fletcher CT/MR applicator (Part#189.745) and henschke titanium applicator (Part#110.437). According to the sources imaging in the fluorography film, the distance of applicators between the first dwell position and the top could be measured. Marker was pasted on the surface of applicator corresponding to the first dwell position. And then the applicator was put into the pelvic phantom for a CT scan. During applicator reconstruction in the treatment planning system, the Offset values of all applicators could be acquired through adjusting the value of offset to superimpose the first dwell and the marker images. On account of the density of plastic material applicators were similar to human tissues, it was difficult to reconstruct the top of the applicator. With the help of stopper or simulation source, the value of offset could be acquired for plastic material applicators. Based on the measurement results, the differences were analyzed among different applicators. Results The Offset values significantly differed among various applicators. The Offset value for stainless steel interstitial needle was -11.4 mm, -4.1 mm for proguide round needle, -3.5 mm for proguide sharp needle, 0 mm or -5.0 mm for vaginal multi-channel applicator, -6.5 mm for fletcher CT/MR applicator and -7.5 mm for henschke titanium applicator, respectively. Conclusion To adapt to the rapid development of precise radiotherapy, it is necessary to verify the Offset value in afterloading brachytherapy. Key words: Applicator reconstruction; Offset value; Radionuclide imaging
目的探讨不同应用器在后装近距离放射治疗中的偏置值。方法选用不锈钢间质针(083.062件)、proguide圆针(189.608件)、proguide尖针(189.601件)、阴道多通道敷贴器(110.800件)、,fletcher CT/MR探头(零件号189.745)和henschke钛探头(零件编号110.437)。根据荧光成像胶片中的源成像,可以测量探头在第一停留位置和顶部之间的距离。标记被粘贴在与第一停留位置相对应的施用器的表面上。然后将敷贴器放入骨盆模型中进行CT扫描。在治疗计划系统中的涂抹器重建过程中,可以通过调整偏移值来获取所有涂抹器的偏移值,以叠加第一停留图像和标记图像。由于塑料材料涂抹器的密度与人体组织相似,因此很难重建涂抹器的顶部。借助于塞子或模拟源,可以获得塑料材料涂敷器的偏移值。根据测量结果,分析了不同喷头之间的差异。结果不同用药者的偏移值存在显著差异。不锈钢间质针的偏移值为-11.4 mm,导前圆针为-4.1 mm,导尖针为-3.5 mm,阴道多通道敷料器为0 mm或-5.0 mm,fletcher CT/MR敷料器为-6.5 mm,henschke钛敷料器为-7.5 mm。结论为了适应精确放射治疗的快速发展,有必要验证后装近距离放射治疗中的偏移值。关键词:治疗探头重建;偏移值;放射性核素成像
{"title":"A verification study of Offset values of different applicators in afterloading brachytherapy","authors":"Min Liu, Xianliang Wang, K. Yuan, B. Wan, Feng Yang, Shengwei Kang, Jie Li","doi":"10.3760/CMA.J.ISSN.1004-4221.2020.02.011","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1004-4221.2020.02.011","url":null,"abstract":"Objective \u0000To investigate the Offset values of different applicators in afterloading brachytherapy. \u0000 \u0000 \u0000Methods \u0000Six types of applicators were selected in this study which included stainless steel interstitial needle (Part#083.062), proguide round needle (Part#189.608), proguide sharp needle (Part#189.601), vaginal multi-channel applicator (Part#110.800), fletcher CT/MR applicator (Part#189.745) and henschke titanium applicator (Part#110.437). According to the sources imaging in the fluorography film, the distance of applicators between the first dwell position and the top could be measured. Marker was pasted on the surface of applicator corresponding to the first dwell position. And then the applicator was put into the pelvic phantom for a CT scan. During applicator reconstruction in the treatment planning system, the Offset values of all applicators could be acquired through adjusting the value of offset to superimpose the first dwell and the marker images. On account of the density of plastic material applicators were similar to human tissues, it was difficult to reconstruct the top of the applicator. With the help of stopper or simulation source, the value of offset could be acquired for plastic material applicators. Based on the measurement results, the differences were analyzed among different applicators. \u0000 \u0000 \u0000Results \u0000The Offset values significantly differed among various applicators. The Offset value for stainless steel interstitial needle was -11.4 mm, -4.1 mm for proguide round needle, -3.5 mm for proguide sharp needle, 0 mm or -5.0 mm for vaginal multi-channel applicator, -6.5 mm for fletcher CT/MR applicator and -7.5 mm for henschke titanium applicator, respectively. \u0000 \u0000 \u0000Conclusion \u0000To adapt to the rapid development of precise radiotherapy, it is necessary to verify the Offset value in afterloading brachytherapy. \u0000 \u0000 \u0000Key words: \u0000Applicator reconstruction; Offset value; Radionuclide imaging","PeriodicalId":10288,"journal":{"name":"Chinese Journal of Radiation Oncology","volume":"29 1","pages":"126-130"},"PeriodicalIF":0.0,"publicationDate":"2020-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46625174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Feasibility of automatic IMRT planning for cervical cancer based on a database of previously-treated patients 基于既往治疗患者数据库的癌症IMRT自动规划的可行性
Pub Date : 2020-02-15 DOI: 10.3760/CMA.J.ISSN.1004-4221.2020.02.014
Jihong Chen, P. Bai, Wenjuan Chen, Kaiqiang Chen, Qi-xin Li, Xiu-chun Zhang, Yitao Dai, X. Weng, Jiewei Qian
Objective To develop and evaluate an automatic intensity-modulated radiation therapy (IMRT) program for cervical cancer based on a database of overlap volume histogram (OVH) and high-quality cervical IMRT plans for previously-treated patients. Methods A database consisting of high-quality IMRT plans and OVHs from 200 cervical cancer patients was established. OVHs of another 26 cervical cancer patients were converted into gray level images to calculate the image similarity compared with those from the database. The planning optimization function of the patients from the database with the highest image similarity was selected and inherent Pinnacle3 scripts were utilized to automatically generate IMRT plan. Finally, the dosimetric parameters, plan quality and design time were statistically compared between the automatic and manual plans. Results The target coverage, conformity index and homogeneity index did not significantly differ between two plans (all P>0.05). The V40, V45 and mean dose for the rectum in the automatic plans were significantly decreased by 6.1%, 1.3% and 50.7 cGy than those in the manual plans (all P 0.05). The plan design time was shortened by 71% in the automatic plans. Conclusions The automatic IMRT plans based on a database of OVH and high-quality IMRT plans can not only significantly shorten the plan design time, but also reduce the irradiated dose of normal tissues without compromising the target coverage and conformity index. Key words: Cervical neoplasm/intensity-modulated radiation therapy; Overlap volume histogram; Automatic plan
目的基于重叠体积直方图(OVH)数据库和高质量宫颈IMRT计划,开发并评价癌症自动调强放射治疗(IMRT)方案。方法建立一个由200例癌症患者的高质量IMRT计划和OVH组成的数据库。将另外26例癌症患者的OVH转换为灰度图像,以计算图像与数据库中的图像的相似性。从具有最高图像相似性的数据库中选择患者的计划优化功能,并利用固有的Pinnacle3脚本自动生成IMRT计划。最后,对自动和手动计划的剂量测量参数、计划质量和设计时间进行了统计比较。结果两种方案的目标覆盖率、一致性指数和同质性指数差异无统计学意义(均P>0.05),自动方案的V40、V45和直肠平均剂量分别比手动方案显著降低6.1%、1.3%和50.7cGy(均P<0.05),方案设计时间缩短71%。结论基于OVH数据库和高质量IMRT计划的自动IMRT计划不仅可以显著缩短计划设计时间,而且可以在不影响目标覆盖率和一致性指数的情况下降低正常组织的照射剂量。关键词:宫颈肿瘤/调强放射治疗;重叠体积直方图;自动计划
{"title":"Feasibility of automatic IMRT planning for cervical cancer based on a database of previously-treated patients","authors":"Jihong Chen, P. Bai, Wenjuan Chen, Kaiqiang Chen, Qi-xin Li, Xiu-chun Zhang, Yitao Dai, X. Weng, Jiewei Qian","doi":"10.3760/CMA.J.ISSN.1004-4221.2020.02.014","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1004-4221.2020.02.014","url":null,"abstract":"Objective \u0000To develop and evaluate an automatic intensity-modulated radiation therapy (IMRT) program for cervical cancer based on a database of overlap volume histogram (OVH) and high-quality cervical IMRT plans for previously-treated patients. \u0000 \u0000 \u0000Methods \u0000A database consisting of high-quality IMRT plans and OVHs from 200 cervical cancer patients was established. OVHs of another 26 cervical cancer patients were converted into gray level images to calculate the image similarity compared with those from the database. The planning optimization function of the patients from the database with the highest image similarity was selected and inherent Pinnacle3 scripts were utilized to automatically generate IMRT plan. Finally, the dosimetric parameters, plan quality and design time were statistically compared between the automatic and manual plans. \u0000 \u0000 \u0000Results \u0000The target coverage, conformity index and homogeneity index did not significantly differ between two plans (all P>0.05). The V40, V45 and mean dose for the rectum in the automatic plans were significantly decreased by 6.1%, 1.3% and 50.7 cGy than those in the manual plans (all P 0.05). The plan design time was shortened by 71% in the automatic plans. \u0000 \u0000 \u0000Conclusions \u0000The automatic IMRT plans based on a database of OVH and high-quality IMRT plans can not only significantly shorten the plan design time, but also reduce the irradiated dose of normal tissues without compromising the target coverage and conformity index. \u0000 \u0000 \u0000Key words: \u0000Cervical neoplasm/intensity-modulated radiation therapy; Overlap volume histogram; Automatic plan","PeriodicalId":10288,"journal":{"name":"Chinese Journal of Radiation Oncology","volume":"29 1","pages":"141-145"},"PeriodicalIF":0.0,"publicationDate":"2020-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44476545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of locoregional risk factors on long-term prognosis of patients with N0 stage esophageal cancer receiving intensity-modulated radiotherapy 局部危险因素对N0期食管癌症强化放疗患者长期预后的影响
Pub Date : 2020-02-15 DOI: 10.3760/CMA.J.ISSN.1004-4221.2020.02.004
W. Shen, Hong-mei Gao, Jinrui Xu, Y. Cao, Shu-guang Li, You-mei Li, Shuchai Zhu
Objective To evaluate the effect of locoregional risk factors of esophageal cancer on the recurrence of gross tumor volume (GTV) in patients with N0 esophageal squamous cell carcinoma after radical intensity-modulated radiotherapy (IMRT) and to evaluate its effect on the 10-year survival of patients. Methods Clinical data of 374 patients with clinical N0 esophageal squamous cell carcinoma who underwent radical IMRT in the Fourth Hospital of Hebei Medical University from 2005 to 2010 were retrospectively analyzed. Involved-field irradiation was performed in 284 patients and selective lymph node irradiation was given in 90 patients. Concurrent radiochemotherapy was conducted in 69l patients and sequential radiochemotherapy was performed in 38 patients. The survival analysis was carried out by Kaplan-Meier method. The prognosis analysis was performed by multivariate Cox’s regression model. Results A total of 143 patients (38.2%) had recurrence in GTV. The maximum transverse diameter (GTV-D), GTV volume (GTV-V) and GTV volume/length (GTV-V/L) of GTV patients were significantly longer than those without recurrence in GTV (P=0.008, 0.043, 0.001). ROC curve analysis showed that the optimal diagnostic thresholds for GTV-D, GTV-L, GTV-V and GTV-V/L for GTV recurrence were 3.5 cm, 5.5 cm, 24.0 cm3 and 4.6 cm2, respectively (P=0.000, 0.003, 0.000 and 0.000), and the ratio of recurrence within GTV in the patient group was significantly greater than that in the smaller group (P=0.000, 0.002, 0.001 and 0.000). GTV-L and GTV-V/L were the independent risk factors of recurrence in GTV (P=0.021 and 0.009). The 3-, 5-and 10-year survival rates of all patients in the whole group were 42.9%, 23.2% and 7.9%, respectively. Multivariate analysis demonstrated that age, T stage, concurrent radiochemotherapy, GTV-D and GTV-V/L were the independent risk factors of survival (P=0.027, 0.000, 0.018, 0.009 and 0.034). The main cause of death in patients with a survival time of more than 5 years was still associated with cancer. Conclusions The locoregional risk factors of esophageal cancer exert significant effect on the recurrence of GTV in patients with N0 esophageal squamous cell carcinoma undergoing radical radiochemotherapy, which can be utilized as the predicting markers. Both GTV-D and GTV-V/L are significantly correlated the 10-year survival of patients. Key words: Esophageal neoplasm/radiochemotherapy; Recurrence of primary tumor bed; Prognosis
目的探讨癌症局部危险因素对N0食管鳞状细胞癌根治性调强放疗(IMRT)后总肿瘤体积(GTV)复发的影响及其对10年生存率的影响。方法回顾性分析2005~2010年河北医科大学第四医院374例临床N0食管鳞状细胞癌根治性IMRT患者的临床资料。284例患者行受累野照射,90例患者行选择性淋巴结照射。69例患者同时进行放化疗,38例患者依次进行放化疗。采用Kaplan-Meier法进行生存分析。预后分析采用多变量Cox回归模型。结果GTV复发143例,占38.2%。GTV患者的最大横径(GTV-D)、GTV体积(GTV-V)和GTV体积/长度(GTV-V/L)明显长于GTV无复发者(P=0.008、0.043、0.001),GTV-L和GTV-V/L是GTV复发的独立危险因素(P=0.021和0.009)。整个组所有患者的3、5和10年生存率分别为42.9%、23.2%和7.9%,分别地多因素分析表明,年龄、T分期、同期放化疗、GTV-D和GTV-V/L是生存的独立危险因素(P=0.027、0.000、0.018、0.009和0.034),生存时间超过5年的患者的主要死亡原因仍与癌症有关。结论食管癌症局部危险因素对N0食管鳞状细胞癌根治性放化疗后GTV复发有显著影响,可作为预测标志。GTV-D和GTV-V/L与患者的10年生存率显著相关。关键词:食管肿瘤/放化疗;原发性肿瘤床复发;预后
{"title":"Effect of locoregional risk factors on long-term prognosis of patients with N0 stage esophageal cancer receiving intensity-modulated radiotherapy","authors":"W. Shen, Hong-mei Gao, Jinrui Xu, Y. Cao, Shu-guang Li, You-mei Li, Shuchai Zhu","doi":"10.3760/CMA.J.ISSN.1004-4221.2020.02.004","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1004-4221.2020.02.004","url":null,"abstract":"Objective \u0000To evaluate the effect of locoregional risk factors of esophageal cancer on the recurrence of gross tumor volume (GTV) in patients with N0 esophageal squamous cell carcinoma after radical intensity-modulated radiotherapy (IMRT) and to evaluate its effect on the 10-year survival of patients. \u0000 \u0000 \u0000Methods \u0000Clinical data of 374 patients with clinical N0 esophageal squamous cell carcinoma who underwent radical IMRT in the Fourth Hospital of Hebei Medical University from 2005 to 2010 were retrospectively analyzed. Involved-field irradiation was performed in 284 patients and selective lymph node irradiation was given in 90 patients. Concurrent radiochemotherapy was conducted in 69l patients and sequential radiochemotherapy was performed in 38 patients. The survival analysis was carried out by Kaplan-Meier method. The prognosis analysis was performed by multivariate Cox’s regression model. \u0000 \u0000 \u0000Results \u0000A total of 143 patients (38.2%) had recurrence in GTV. The maximum transverse diameter (GTV-D), GTV volume (GTV-V) and GTV volume/length (GTV-V/L) of GTV patients were significantly longer than those without recurrence in GTV (P=0.008, 0.043, 0.001). ROC curve analysis showed that the optimal diagnostic thresholds for GTV-D, GTV-L, GTV-V and GTV-V/L for GTV recurrence were 3.5 cm, 5.5 cm, 24.0 cm3 and 4.6 cm2, respectively (P=0.000, 0.003, 0.000 and 0.000), and the ratio of recurrence within GTV in the patient group was significantly greater than that in the smaller group (P=0.000, 0.002, 0.001 and 0.000). GTV-L and GTV-V/L were the independent risk factors of recurrence in GTV (P=0.021 and 0.009). The 3-, 5-and 10-year survival rates of all patients in the whole group were 42.9%, 23.2% and 7.9%, respectively. Multivariate analysis demonstrated that age, T stage, concurrent radiochemotherapy, GTV-D and GTV-V/L were the independent risk factors of survival (P=0.027, 0.000, 0.018, 0.009 and 0.034). The main cause of death in patients with a survival time of more than 5 years was still associated with cancer. \u0000 \u0000 \u0000Conclusions \u0000The locoregional risk factors of esophageal cancer exert significant effect on the recurrence of GTV in patients with N0 esophageal squamous cell carcinoma undergoing radical radiochemotherapy, which can be utilized as the predicting markers. Both GTV-D and GTV-V/L are significantly correlated the 10-year survival of patients. \u0000 \u0000 \u0000Key words: \u0000Esophageal neoplasm/radiochemotherapy; Recurrence of primary tumor bed; Prognosis","PeriodicalId":10288,"journal":{"name":"Chinese Journal of Radiation Oncology","volume":"29 1","pages":"96-101"},"PeriodicalIF":0.0,"publicationDate":"2020-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43425980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation and prediction of pelvic dose in postoperative IMRT for cervical cancer 宫颈癌症术后IMRT中盆腔剂量的评价与预测
Pub Date : 2020-02-15 DOI: 10.3760/CMA.J.ISSN.1004-4221.2020.02.013
Yanze Sun, Yongqiang Yang, J. Qian
Objective To evaluate and predict the pelvic dose by analyzing two pelvic contour definitions and identify the influencing factors of the pelvic dose in postoperative IMRT for cervical cancer, aiming to provide reference for postoperative pelvis-sparing IMRT for cervical cancer. Methods Sixty cervical cancer patients receiving postoperative IMRT with unrestricted pelvic dose were selected. Two sets of pelvic contours (pelvic anatomy and pelvic Mell) were delineated as per the anatomical and Mell methods. The dose relationship between two methods was analyzed after redesigning the treatment plan by limiting dose of pelvic anatomy. The correlation analysis was performed by Pearson’s correlation method. The factors affecting the pelvic anatomy dose were identified by Logistic multivariate regression analysis and a dose prediction model was subsequently established. Results The volumes of pelvic anatomy and pelvic Mell were 925.82 cm3 and 1141.20 cm3(P=0.000). There was a significant correlation between them (r>0.622, P=0.000). The dose of pelvic anatomy was significantly higher than that of pelvic Mell. The relationship of V10, V20 and V30 between them was y=-8+ 1.01x, y=-13+ 1.05x and y=-4+ 0.9x, respectively. The dose limits of pelvic Mell recommended by literatures(V10<90%, V20<75%, V30<60%) were translated into V10<97%, V20<83% and V30<70%, respectively. The pelvic anatomy dose was significantly reduced after dose limiting. The V10, V20, V30 and Dmean were significantly decreased by 3.64%, 12.69%, 12.02% and 6.93%(P=0.000, 0.000, 0.000), respectively. Multivariate analysis showed that the overlapping volume of pelvic anatomy within PTV was an independent influencing factor of pelvic anatomy dose (P<0.05). Patients with a relative overlapping volume of less than 18% could easily meet the dose limiting requirement. Conclusions Both two pelvic contour definitions can be applied in postoperative pelvis-sparing IMRT for cervical cancer. Use of pelvic dose limiting can significantly reduce the IMRT dose. The overlapping volume of the pelvis within PTV is an independent influencing factor of pelvic dose. Patients whose overlapping volume within the PTV relative to pelvis is less than 18% can easily meet the dose limiting requirement. Key words: Cervical cancer/intensity-modulated radiotherapy; Pelvis; Dosimetry
目的通过分析两种骨盆轮廓定义,评价和预测癌症术后IMRT中骨盆剂量的影响因素,为癌症术后盆腔切开IMRT提供参考。方法选择60例癌症患者术后接受不限制骨盆剂量IMRT。根据解剖和Mell方法绘制了两组骨盆轮廓(骨盆解剖和骨盆Mell)。在通过限制骨盆解剖的剂量重新设计治疗方案后,分析了两种方法之间的剂量关系。相关分析采用Pearson相关法。通过Logistic多元回归分析确定了影响骨盆解剖剂量的因素,并随后建立了剂量预测模型。结果骨盆解剖体积和骨盆Mell体积分别为925.82 cm3和1141.20 cm3(P=0.000),二者之间存在显著相关性(r>0.622,P=0.000)。V10、V20和V30之间的关系分别为y=-8+1.01x、y=-13+1.05x和y=-4+0.9x。文献推荐的盆腔Mell剂量限值(V10<90%,V20<75%,V30<60%)分别转化为V10<97%,V20<13%和V30<70%。剂量限制后,骨盆解剖部位的剂量显著减少。V10、V20、V30和Dmean分别显著下降3.64%、12.69%、12.02%和6.93%(P=0.000、0.000、0.000)。多因素分析表明,PTV内骨盆解剖结构的重叠体积是骨盆解剖结构剂量的独立影响因素(P<0.05),相对重叠体积小于18%的患者可以很容易地满足剂量限制要求。结论两种骨盆轮廓定义均可应用于癌症术后盆腔切开IMRT。使用骨盆剂量限制可以显著降低IMRT剂量。PTV内骨盆的重叠体积是骨盆剂量的独立影响因素。PTV内相对于骨盆的重叠体积小于18%的患者可以很容易地满足剂量限制要求。关键词:宫颈癌症/调强放疗;骨盆;剂量测定法
{"title":"Evaluation and prediction of pelvic dose in postoperative IMRT for cervical cancer","authors":"Yanze Sun, Yongqiang Yang, J. Qian","doi":"10.3760/CMA.J.ISSN.1004-4221.2020.02.013","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1004-4221.2020.02.013","url":null,"abstract":"Objective \u0000To evaluate and predict the pelvic dose by analyzing two pelvic contour definitions and identify the influencing factors of the pelvic dose in postoperative IMRT for cervical cancer, aiming to provide reference for postoperative pelvis-sparing IMRT for cervical cancer. \u0000 \u0000 \u0000Methods \u0000Sixty cervical cancer patients receiving postoperative IMRT with unrestricted pelvic dose were selected. Two sets of pelvic contours (pelvic anatomy and pelvic Mell) were delineated as per the anatomical and Mell methods. The dose relationship between two methods was analyzed after redesigning the treatment plan by limiting dose of pelvic anatomy. The correlation analysis was performed by Pearson’s correlation method. The factors affecting the pelvic anatomy dose were identified by Logistic multivariate regression analysis and a dose prediction model was subsequently established. \u0000 \u0000 \u0000Results \u0000The volumes of pelvic anatomy and pelvic Mell were 925.82 cm3 and 1141.20 cm3(P=0.000). There was a significant correlation between them (r>0.622, P=0.000). The dose of pelvic anatomy was significantly higher than that of pelvic Mell. The relationship of V10, V20 and V30 between them was y=-8+ 1.01x, y=-13+ 1.05x and y=-4+ 0.9x, respectively. The dose limits of pelvic Mell recommended by literatures(V10<90%, V20<75%, V30<60%) were translated into V10<97%, V20<83% and V30<70%, respectively. The pelvic anatomy dose was significantly reduced after dose limiting. The V10, V20, V30 and Dmean were significantly decreased by 3.64%, 12.69%, 12.02% and 6.93%(P=0.000, 0.000, 0.000), respectively. Multivariate analysis showed that the overlapping volume of pelvic anatomy within PTV was an independent influencing factor of pelvic anatomy dose (P<0.05). Patients with a relative overlapping volume of less than 18% could easily meet the dose limiting requirement. \u0000 \u0000 \u0000Conclusions \u0000Both two pelvic contour definitions can be applied in postoperative pelvis-sparing IMRT for cervical cancer. Use of pelvic dose limiting can significantly reduce the IMRT dose. The overlapping volume of the pelvis within PTV is an independent influencing factor of pelvic dose. Patients whose overlapping volume within the PTV relative to pelvis is less than 18% can easily meet the dose limiting requirement. \u0000 \u0000 \u0000Key words: \u0000Cervical cancer/intensity-modulated radiotherapy; Pelvis; Dosimetry","PeriodicalId":10288,"journal":{"name":"Chinese Journal of Radiation Oncology","volume":"29 1","pages":"136-140"},"PeriodicalIF":0.0,"publicationDate":"2020-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43629969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Clinical diagnosis and treatment of perineural invasion of head and neck malignant tumors 头颈部恶性肿瘤侵袭周围神经的临床诊断与治疗
Pub Date : 2020-02-15 DOI: 10.3760/CMA.J.ISSN.1004-4221.2020.02.015
Zekun Wang
Perineural invasion is a unique biological behavior of tumors via nerve dissemination and metastasis, which is intimately correlated with the recurrence, metastasis and prognosis. With the deepening research, the clinical significance of perineural invasion has been widely recognized. However, due to the low incidence of head and neck neoplasms and the varying incidence of perineural invasion in different anatomical sites and pathological types, high-level evidence-based medical evidence is still lacking. Currently, the pathological mechanism of perineural invasion has not been clearly clarified. No specific treatment has been available for perineural invasion. Therefore, the treatment of perineural invasion of head and neck tumors is an enormous challenge for clinicians. In this article, the current status of clinical diagnosis and treatment of perineural invasion in head and neck malignancies was reviewed. Key words: Head and neck neoplasm; Perineural invasion; Diagnosis and treatment
神经周围浸润是肿瘤通过神经播散和转移的一种独特的生物学行为,与肿瘤的复发、转移和预后密切相关。随着研究的不断深入,神经周围侵犯的临床意义已被广泛认识。然而,由于头颈部肿瘤的发病率较低,且不同解剖部位和病理类型对神经周围侵袭的发生率不同,目前仍缺乏高水平的循证医学证据。目前,神经周围浸润的病理机制尚未明确。对于神经周围浸润没有特殊的治疗方法。因此,头颈部肿瘤侵袭周围神经的治疗对临床医生来说是一个巨大的挑战。本文就头颈部恶性肿瘤侵袭周围神经的临床诊断和治疗现状作一综述。关键词:头颈部肿瘤;围神经的入侵;诊断与治疗
{"title":"Clinical diagnosis and treatment of perineural invasion of head and neck malignant tumors","authors":"Zekun Wang","doi":"10.3760/CMA.J.ISSN.1004-4221.2020.02.015","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1004-4221.2020.02.015","url":null,"abstract":"Perineural invasion is a unique biological behavior of tumors via nerve dissemination and metastasis, which is intimately correlated with the recurrence, metastasis and prognosis. With the deepening research, the clinical significance of perineural invasion has been widely recognized. However, due to the low incidence of head and neck neoplasms and the varying incidence of perineural invasion in different anatomical sites and pathological types, high-level evidence-based medical evidence is still lacking. Currently, the pathological mechanism of perineural invasion has not been clearly clarified. No specific treatment has been available for perineural invasion. Therefore, the treatment of perineural invasion of head and neck tumors is an enormous challenge for clinicians. In this article, the current status of clinical diagnosis and treatment of perineural invasion in head and neck malignancies was reviewed. \u0000 \u0000 \u0000Key words: \u0000Head and neck neoplasm; Perineural invasion; Diagnosis and treatment","PeriodicalId":10288,"journal":{"name":"Chinese Journal of Radiation Oncology","volume":"29 1","pages":"146-149"},"PeriodicalIF":0.0,"publicationDate":"2020-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46875097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中华放射肿瘤学杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1